BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7576047)

  • 1. BTKbase: a database of XLA-causing mutations. International Study Group.
    Vihinen M; Cooper MD; de Saint Basile G; Fischer A; Good RA; Hendriks RW; Kinnon C; Kwan SP; Litman GW; Notarangelo LD
    Immunol Today; 1995 Oct; 16(10):460-5. PubMed ID: 7576047
    [No Abstract]   [Full Text] [Related]  

  • 2. BTKbase: XLA-mutation registry.
    Vihinen M; Brooimans RA; Kwan SP; Lehväslaiho H; Litman GW; Ochs HD; Resnick I; Schwaber JH; Vorĕchovsky I; Smith CI
    Immunol Today; 1996 Nov; 17(11):502-6. PubMed ID: 8961625
    [No Abstract]   [Full Text] [Related]  

  • 3. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
    Vihinen M; Brandau O; Brandén LJ; Kwan SP; Lappalainen I; Lester T; Noordzij JG; Ochs HD; Ollila J; Pienaar SM; Riikonen P; Saha BK; Smith CI
    Nucleic Acids Res; 1998 Jan; 26(1):242-7. PubMed ID: 9399844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
    Vihinen M; Belohradsky BH; Haire RN; Holinski-Feder E; Kwan SP; Lappalainen I; Lehväslaiho H; Lester T; Meindl A; Ochs HD; Ollila J; Vorechovsky I; Weiss M; Smith CI
    Nucleic Acids Res; 1997 Jan; 25(1):166-71. PubMed ID: 9016530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA).
    Vihinen M; Mattsson PT; Smith CI
    Front Biosci; 2000 Dec; 5():D917-28. PubMed ID: 11102316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease.
    Mattsson PT; Vihinen M; Smith CI
    Bioessays; 1996 Oct; 18(10):825-34. PubMed ID: 8885720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of the human BTK gene coding for bruton tyrosine kinase in X-linked agammaglobulinemia.
    Vihinen M; Kwan SP; Lester T; Ochs HD; Resnick I; Väliaho J; Conley ME; Smith CI
    Hum Mutat; 1999; 13(4):280-5. PubMed ID: 10220140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BTK, the tyrosine kinase affected in X-linked agammaglobulinemia.
    Vihinen M; Mattsson PT; Smith CI
    Front Biosci; 1997 Jan; 2():d27-42. PubMed ID: 9159207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: phosphotyrosine-binding and circular dichroism analysis.
    Mattsson PT; Lappalainen I; Bäckesjö CM; Brockmann E; Laurén S; Vihinen M; Smith CI
    J Immunol; 2000 Apr; 164(8):4170-7. PubMed ID: 10754312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA).
    Jin H; Webster AD; Vihinen M; Sideras P; Vorechovsky I; Hammarstróm L; Bernatowska-Matuszkiewicz E; Smith CI; Bobrow M; Vetrie D
    Hum Mol Genet; 1995 Apr; 4(4):693-700. PubMed ID: 7633420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSCP at the BTK locus.
    Vorechovský I
    Hum Mol Genet; 1994 Jun; 3(6):1031. PubMed ID: 7951224
    [No Abstract]   [Full Text] [Related]  

  • 12. BTKbase, mutation database for X-linked agammaglobulinemia (XLA).
    Vihinen M; Iwata T; Kinnon C; Kwan SP; Ochs HD; Vorechovský I; Smith CI
    Nucleic Acids Res; 1996 Jan; 24(1):160-5. PubMed ID: 8594569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique mutations of Bruton's tyrosine kinase in fourteen unrelated X-linked agammaglobulinemia families.
    Zhu Q; Zhang M; Winkelstein J; Chen SH; Ochs HD
    Hum Mol Genet; 1994 Oct; 3(10):1899-900. PubMed ID: 7849721
    [No Abstract]   [Full Text] [Related]  

  • 14. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes.
    Thomas JD; Sideras P; Smith CI; Vorechovský I; Chapman V; Paul WE
    Science; 1993 Jul; 261(5119):355-8. PubMed ID: 8332900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.
    Brooimans RA; van den Berg AJ; Rijkers GT; Sanders LA; van Amstel JK; Tilanus MG; Grubben MJ; Zegers BJ
    J Med Genet; 1997 Jun; 34(6):484-8. PubMed ID: 9192269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion within the Src homology domain 3 of Bruton's tyrosine kinase resulting in X-linked agammaglobulinemia (XLA).
    Zhu Q; Zhang M; Rawlings DJ; Vihinen M; Hagemann T; Saffran DC; Kwan SP; Nilsson L; Smith CI; Witte ON; Chen SH; Ochs HD
    J Exp Med; 1994 Aug; 180(2):461-70. PubMed ID: 7519238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis for X-linked agammaglobulinemia (XLA): mutations at interacting Btk residues R562, W563, and A582.
    Maniar HS; Vihinen M; Webster AD; Nilsson L; Smith CI
    Clin Immunol Immunopathol; 1995 Sep; 76(3 Pt 2):S198-202. PubMed ID: 7554468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. X-linked agammaglobulinemia and Bruton's tyrosine kinase.
    Tsukada S; Witte ON
    Adv Exp Med Biol; 1994; 365():233-8. PubMed ID: 7887309
    [No Abstract]   [Full Text] [Related]  

  • 19. Mutation analysis of the Bruton's tyrosine kinase gene in X-linked agammaglobulinemia: identification of a mutation which affects the same codon as is altered in immunodeficient xid mice.
    de Weers M; Mensink RG; Kraakman ME; Schuurman RK; Hendriks RW
    Hum Mol Genet; 1994 Jan; 3(1):161-6. PubMed ID: 8162018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-chromosome inactivation and mutation pattern in the Bruton's tyrosine kinase gene in patients with X-linked agammaglobulinemia. Italian XLA Collaborative Group.
    Moschese V; Orlandi P; Plebani A; Arvanitidis K; Fiorini M; Speletas M; Mella P; Ritis K; Sideras P; Finocchi A; Livadiotti S; Rossi P
    Mol Med; 2000 Feb; 6(2):104-13. PubMed ID: 10859027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.